In our study, all sPD-L1, sPD-1, and sADO levels were significantly higher in the CD38-positive CLL patients when compared to the CD38-negative CLL patients (P-value < 0.01) (Table 5). The gene discussed is CD38; the disease is B-cell chronic lymphocytic leukemia.